nk rel="canonical" href="https://cdoc101.com/foto-en.php?id=3030">

Chinese Doctors Directory Chinese Medical School Graduates Gathering in North America


BackNext
Dr. Qiu, Weiqiao Wendy

Dr. Qiu, Weiqiao WendyMD, PhD

邱唯乔

Psychiatry Geriatric Psychiatry

Other Psychiatry Physicians Nearby

中文

Clinic

New England Medical Center

Address
72 East Concord St
Boston, MA 02118 美国
Get Direction →
Phone
617-638-4336
Fax
617.638.5254
Email
wqiu67@bu.edu

Education and Training

Medical School
Beijing, Peking University Health Science Center
Residency
Tufts Medical Center, 2002
Graduation Year
1982

Clinical Interests

late life depression and anxiety, and sees patients at BU ADRC for clinical trials.

Languages

In addition to English, this physician speaks Mandarin..

Additional Information

Certification: Board Certified in Psychiatry

Ph.D.: Cornell Medical College

Research Interests:
Identifying and studying the modifiable and non-modifiable risk factors and their mechanisms in Alzheimer¡¯s disease (AD): We have an established homebound elderly population in the Boston area, and we are performing longitudinal evaluations of their cognition, psychiatric, and neurological conditions. Some of the homebound elderly have also taken part in brain imaging. Our study focuses on the relationship between late life depression, type 2 diabetes, and AD. Investigating the brain¡¯s regulation of emotion, obesity/diabetes, and cognition in AD pathogenesis will help todevelop novel treatments for the intervention and early treatment of AD.
Identifying and studying the communication between peripheral biomarkers and brain abnormalities in aging and the prodromal stage of AD: We are targeting biomarkers that could lead to an early diagnosis of AD, especially A¦Â peptides and cytopkines found in blood and cerebral spinal fluid. We are also using neuro-imaging such as magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS), to study these biomarkers and brain composition.
Investigating the Insulin Degrading Enzyme: Our study and others have identified that the insulin-degrading enzyme (IDE) plays a key role in the clearance of amyloid beta peptides (A¦Â), a major component in AD pathology. IDE also degrades insulin and amylin, and it might be a key component in type 2 diabetes. Our research goal is to further investigate whether defects of IDE activity and its regulation accelerates AD pathology in the elderly who suffer from type 2 diabetes.

Information Accuracy: Good  ·  Last update: 2024-12-15

Report a correction about this profile BackNext


Privacy Policy Disclaimer Contact



© 2026 Copyright.
Email: cdoc101.com@gmail.com
Wechat: royzhang42